257 related articles for article (PubMed ID: 29077761)
1. In vitro characterization of the antivirulence target of Gram-positive pathogens, peptidoglycan O-acetyltransferase A (OatA).
Sychantha D; Jones CS; Little DJ; Moynihan PJ; Robinson H; Galley NF; Roper DI; Dowson CG; Howell PL; Clarke AJ
PLoS Pathog; 2017 Oct; 13(10):e1006667. PubMed ID: 29077761
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the
Jones CS; Sychantha D; Howell PL; Clarke AJ
J Biol Chem; 2020 Jun; 295(24):8204-8213. PubMed ID: 32350117
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of
Jones CS; Anderson AC; Clarke AJ
Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34480000
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity and kinetic characterization of peptidoglycan O-acetyltransferase B from Neisseria gonorrhoeae.
Moynihan PJ; Clarke AJ
J Biol Chem; 2014 Jun; 289(24):16748-60. PubMed ID: 24795044
[TBL] [Abstract][Full Text] [Related]
5. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.
Bera A; Herbert S; Jakob A; Vollmer W; Götz F
Mol Microbiol; 2005 Feb; 55(3):778-87. PubMed ID: 15661003
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay.
Pushkaran AC; Nataraj N; Nair N; Götz F; Biswas R; Mohan CG
J Chem Inf Model; 2015 Apr; 55(4):760-70. PubMed ID: 25774564
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new family of enzymes with potential O-acetylpeptidoglycan esterase activity in both Gram-positive and Gram-negative bacteria.
Weadge JT; Pfeffer JM; Clarke AJ
BMC Microbiol; 2005 Aug; 5():49. PubMed ID: 16111493
[TBL] [Abstract][Full Text] [Related]
8. OatA, a peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulence.
Aubry C; Goulard C; Nahori MA; Cayet N; Decalf J; Sachse M; Boneca IG; Cossart P; Dussurget O
J Infect Dis; 2011 Sep; 204(5):731-40. PubMed ID: 21844299
[TBL] [Abstract][Full Text] [Related]
9. Peptidoglycan Modification by the Catalytic Domain of Streptococcus pneumoniae OatA Follows a Ping-Pong Bi-Bi Mechanism of Action.
Sychantha D; Clarke AJ
Biochemistry; 2018 Apr; 57(16):2394-2401. PubMed ID: 29595955
[TBL] [Abstract][Full Text] [Related]
10. Dual role for the O-acetyltransferase OatA in peptidoglycan modification and control of cell septation in Lactobacillus plantarum.
Bernard E; Rolain T; David B; André G; Dupres V; Dufrêne YF; Hallet B; Chapot-Chartier MP; Hols P
PLoS One; 2012; 7(10):e47893. PubMed ID: 23110121
[TBL] [Abstract][Full Text] [Related]
11. Development of a High Throughput Screen for the Identification of Inhibitors of Peptidoglycan
Brott AS; Jones CS; Clarke AJ
Antibiotics (Basel); 2019 May; 8(2):. PubMed ID: 31137799
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Pathways for Peptidoglycan O-Acetylation and De-O-Acetylation.
Sychantha D; Brott AS; Jones CS; Clarke AJ
Front Microbiol; 2018; 9():2332. PubMed ID: 30327644
[TBL] [Abstract][Full Text] [Related]
13. Assay for peptidoglycan O-acetyltransferase: a potential new antibacterial target.
Moynihan PJ; Clarke AJ
Anal Biochem; 2013 Aug; 439(2):73-9. PubMed ID: 23660013
[TBL] [Abstract][Full Text] [Related]
14. O-Acetylated peptidoglycan: controlling the activity of bacterial autolysins and lytic enzymes of innate immune systems.
Moynihan PJ; Clarke AJ
Int J Biochem Cell Biol; 2011 Dec; 43(12):1655-9. PubMed ID: 21889603
[TBL] [Abstract][Full Text] [Related]
15. SpxB regulates O-acetylation-dependent resistance of Lactococcus lactis peptidoglycan to hydrolysis.
Veiga P; Bulbarela-Sampieri C; Furlan S; Maisons A; Chapot-Chartier MP; Erkelenz M; Mervelet P; Noirot P; Frees D; Kuipers OP; Kok J; Gruss A; Buist G; Kulakauskas S
J Biol Chem; 2007 Jul; 282(27):19342-54. PubMed ID: 17485463
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of Peptidoglycan O-Acetylation Leads to Altered Cell Wall Biochemistry and Negatively Impacts Pathogenesis Factors of Campylobacter jejuni.
Ha R; Frirdich E; Sychantha D; Biboy J; Taveirne ME; Johnson JG; DiRita VJ; Vollmer W; Clarke AJ; Gaynor EC
J Biol Chem; 2016 Oct; 291(43):22686-22702. PubMed ID: 27474744
[TBL] [Abstract][Full Text] [Related]
17. Characterization of O-acetylation of N-acetylglucosamine: a novel structural variation of bacterial peptidoglycan.
Bernard E; Rolain T; Courtin P; Guillot A; Langella P; Hols P; Chapot-Chartier MP
J Biol Chem; 2011 Jul; 286(27):23950-8. PubMed ID: 21586574
[TBL] [Abstract][Full Text] [Related]
18. Postsynthetic Modification of Bacterial Peptidoglycan Using Bioorthogonal N-Acetylcysteamine Analogs and Peptidoglycan O-Acetyltransferase B.
Wang Y; Lazor KM; DeMeester KE; Liang H; Heiss TK; Grimes CL
J Am Chem Soc; 2017 Oct; 139(39):13596-13599. PubMed ID: 28898061
[TBL] [Abstract][Full Text] [Related]
19. Bacillus subtilis σ(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids.
Guariglia-Oropeza V; Helmann JD
J Bacteriol; 2011 Nov; 193(22):6223-32. PubMed ID: 21926231
[TBL] [Abstract][Full Text] [Related]
20. Acetylation of Surface Carbohydrates in Bacterial Pathogens Requires Coordinated Action of a Two-Domain Membrane-Bound Acyltransferase.
Pearson CR; Tindall SN; Herman R; Jenkins HT; Bateman A; Thomas GH; Potts JR; Van der Woude MW
mBio; 2020 Aug; 11(4):. PubMed ID: 32843546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
